US drug overdose deaths fell 27 pc last year: CDC

IANS May 15, 2025 256 views

The United States has experienced its largest one-year decline in drug overdose deaths, with approximately 80,000 fatalities in 2024 compared to 110,000 in 2023. Experts attribute this significant drop to increased naloxone availability, expanded addiction treatment, and shifting drug use patterns. Despite this promising trend, the CDC emphasizes that overdoses remain the leading cause of death for young adults aged 18-44. Researchers caution that sustained progress depends on continued funding and strategic public health interventions.

"Overdoses are still the leading cause of death for people 18-44 years old" - CDC Statement
New York, May 15: There were 30,000 fewer US drug overdose deaths in 2024 than the year before, the largest one-year decline ever recorded -- an estimated 80,000 people died from overdoses last year, according to provisional data released by the Centers for Disease Control and Prevention (CDC).

Key Points

1

Major 27% reduction in drug overdose deaths nationwide

2

All states except Nevada saw significant declines

3

Potential factors include naloxone availability and addiction treatment expansion

That went down 27 per cent from the 110,000 in 2023, Xinhua news agency reported on Wednesday.

The CDC has been collecting comparable data for 45 years.

The previous largest one-year drop was 4 per cent in 2018, according to the agency's National Center for Health Statistics.

All but two states saw declines last year, with Nevada and South Dakota seeing small increases.

Some of the biggest drops were in Ohio, West Virginia and other states that have been hard-hit in the nation's decades-long overdose epidemic.

Experts say more research needs to be done to understand what drove the reduction, but they mention several possible factors.

Among the most cited: increased availability of the overdose-reversing drug naloxone, expanded addiction treatment, shifts in how people use drugs, the growing impact of billions of dollars in opioid lawsuit settlement money.

Meanwhile, the number of at-risk Americans is shrinking, after waves of deaths in older adults and a shift in teens and younger adults away from the drugs that cause most deaths.

Still, US annual overdose deaths are higher than they were before the Covid-19 pandemic.

In a statement, the CDC noted that overdoses are still the leading cause of death for people 18-44 years old, "underscoring the need for ongoing efforts to maintain this progress."

Some experts worry that the recent decline could be slowed or stopped by reductions in federal funding and the public health workforce, or a shift away from the strategies that seem to be working.

The provisional numbers are estimates of everyone who died of overdoses in the US, including non-citizens. That data is still being processed, and the final numbers can sometimes differ a bit. But it is clear that there was a huge drop last year.

Experts note that there have been past moments when US overdose deaths seemed to have plateaued or even started to go down, only to rise again. That happened in 2018.

Reader Comments

R
Rajesh K.
This is positive news but also shows how deep the problem was - 80,000 deaths is still shockingly high! India should learn from both their mistakes and solutions. Our own opioid crisis in Punjab shows we're not immune to this.
P
Priya M.
The naloxone availability seems to be making a big difference. We need similar emergency measures for drug overdoses in Indian cities. Mumbai and Delhi are seeing rising cases but no proper systems in place. 😔
A
Amit S.
While this is good, the article mentions funding cuts might reverse progress. America's healthcare system is so complex - in India at least our government hospitals provide basic care to all. Still, 27% drop is impressive!
S
Sunita R.
The youth shift away from dangerous drugs is interesting. In India, we need more awareness programs in colleges about substance abuse. Many students don't realize how prescription drugs can be gateway to addiction.
V
Vikram J.
The opioid lawsuit money making a difference shows how corporate accountability matters. In India, we let pharma companies off too easily when their products cause harm. Need stronger regulations here.
N
Neha T.
While the drop is significant, the article rightly cautions against complacency. We've seen similar temporary improvements in India's drug hotspots too. Sustained efforts are key - one good year doesn't mean the battle is won. 🙏

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Your email won't be published


Disclaimer: Comments here reflect the author's views alone. Insulting or using offensive language against individuals, communities, religion, or the nation is illegal.

Tags: